Literature DB >> 23045557

Drug shortage-associated increase in catheter-related blood stream infection in children.

Matthew W Ralls1, R Alexander Blackwood, Meghan A Arnold, M Luisa Partipilo, James Dimond, Daniel H Teitelbaum.   

Abstract

BACKGROUND: Ethanol lock therapy (ELT) has been shown to reduce the incidence of catheter-related blood stream infections (CRBSI) in intestinal failure (IF) patients. Dosing and frequency remains undefined. Scrutiny of pharmaceutical facilities by the Food and Drug Administration led to the voluntary shutdown of the sole supplier of ethanol, resulting in a nationwide shortage. To conserve supply, we reduced ELT frequency from a daily regimen. We examined the impact that reduction in ELT frequency had on CRBSI in pediatric IF patients.
METHODS: We retrospectively reviewed our parenteral nutrition-dependent IF children. Primary outcome measure was CRBSI per 1000 catheter days after ELT frequency reduction. Data were compared (paired t test) to the same group over 1 year before ethanol shortage and to historical controls.
RESULTS: During the shortage 13 outpatients received ELT. Eight met study criteria. Mean ± SD age was 9.1 ± 7.8 years. Mean CRBSI rate per 1000 catheter days was 0.7 ± 1.3 before ELT shortage. This increased to 6.2 ± 2.5 after frequency reduction (P < .001). This CRBSI rate was similar to historical IF children not on ELT (8.0 ± 5.4). Seven children developed CRBSI after frequency reduction, 6 requiring hospitalization, 2 to the ICU. Mean length of stay (15.5 days) averaged $104,783(± 111,034) in hospital charges. Organisms included Gram-negatives (6), methicillin-resistant Staphylococcus aureus (1), and Candida spp (1).
CONCLUSIONS: ELT frequency reduction resulted in complete failure in CRBSI prophylaxis. The nationwide shortage of this drug has been costly both financially and in patient morbidity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23045557     DOI: 10.1542/peds.2011-3894

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Chemotherapy drug shortages in pediatric oncology: a consensus statement.

Authors:  Matthew Decamp; Steven Joffe; Conrad V Fernandez; Ruth R Faden; Yoram Unguru
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

Review 2.  Premixed vs Compounded Parenteral Nutrition: Effects of Total Parenteral Nutrition Shortage on Clinical Practice.

Authors:  Sara L Bonnes; Kerstin E Austin; Jennifer J Carnell; Bradley R Salonen
Journal:  Curr Nutr Rep       Date:  2019-12

3.  Drug shortages and implications for pediatric patients.

Authors:  Lindsay Butterfield; Jared Cash; Kathy Pham
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

4.  Medicine shortages in Australia: causes, impact and management strategies in the community setting.

Authors:  Yee Xi Tan; Rebekah J Moles; Betty B Chaar
Journal:  Int J Clin Pharm       Date:  2016-07-06

5.  How Broad Should Gram-Negative Coverage Be for Febrile Parenteral Nutrition Dependent Short Bowel Syndrome Patients?

Authors:  Jeremy S Stultz; James H Fly; Bindiya Bagga; Sandra R Arnold; Anushree Algotar; Kelley R Lee
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-01-18       Impact factor: 3.288

6.  Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter-Associated Bloodstream Infection: Impact on Length of Stay, Cost, and Catheter Salvage.

Authors:  Eric McGrath; Wei Du; Madhvi Rajpurkar
Journal:  Clin Pediatr (Phila)       Date:  2017-06-30       Impact factor: 1.168

7.  Outcomes of a drug shortage requiring switching in patients with ulcerative colitis.

Authors:  Daniel R van Langenberg; Richard Kai-Yuan Cheng; Mayur Garg
Journal:  World J Gastrointest Pathophysiol       Date:  2020-04-12

Review 8.  Intestinal failure: a review.

Authors:  Philip Allan; Simon Lal
Journal:  F1000Res       Date:  2018-01-18

9.  Heightened Central Line-associated Blood Stream Infection Risk During a Pandemic.

Authors:  Ethan A Mezoff; David Galloway; Conrad R Cole
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-06       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.